Engineering in vitro microenvironments for translation of cell based therapies f...
Engineering in vitro microenvironments for translation of cell based therapies for tendon repair
Tendon Therapy Train is a research, training and innovation programme for human and equine tendon repair and regeneration that will exploit recent advancements in tissue engineering by self-assembly (TESA) technologies which have...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
MagTendon
Magnetically Assisted Tissue Engineering Technologies for Te...
2M€
Cerrado
Heartbeat
3D-assembly of interactive microgels to grow in vitro vascul...
3M€
Cerrado
DPI2010-20399-C04-03
DISEÑO Y FABRICACION DE UNA PLATAFORMA BIOMIMETICA TIPO SCAF...
208K€
Cerrado
P4 FIT
Perspectives For Future Innovation in Tendon Repair
4M€
Cerrado
DPI2010-20399-C04-02
DISEÑO, CONSTRUCCION Y VALIDACION DE PLATAFORMA BIOMIMETICA...
42K€
Cerrado
DPI2010-20399-C04-01
DISEÑO, CONSTRUCCION Y VALIDACION DE UNA PLATAFORMA BIOMIMET...
188K€
Cerrado
Información proyecto Tendon Therapy Train
Duración del proyecto: 54 meses
Fecha Inicio: 2015-07-27
Fecha Fin: 2020-01-31
Líder del proyecto
UNIVERSITY OF GALWAY
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
4M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Tendon Therapy Train is a research, training and innovation programme for human and equine tendon repair and regeneration that will exploit recent advancements in tissue engineering by self-assembly (TESA) technologies which have led to the clinical translation and commercialisation of advanced therapy medicinal products (ATMPs). Although TESA therapies have the potential to revolutionise healthcare for numerous clinical targets, a lack of researchers with the necessary interdisciplinary skillset to advance the field is limiting clinical translation. Tendon therapy train, a network of 8 beneficiaries and 8 partners (7 universities, 7 companies and 2 hospitals) from six countries across Europe, will train a cohort of 15 researchers to doctoral level in the interdisciplinary area of ATMPs. The innovative credentials of the research and training programme involve engineering suitable ex vivo culture environments that, by mimicking the native tendon tissue milieu (human and equine), will maintain the tenogenic phenotype of tendon derived cells and differentiate non-tendon derived cells (stem cells and dermal fibroblasts) towards the tenogenic lineage, subsequently enabling development of three-dimensional cell-assembled tissue equivalents, the clinical potential of which will be assessed in suitable preclinical models. The comprehensive Tendon Therapy Train programme will equip researchers with transferable inter- and multidisciplinary skills that will further European-based knowledge, innovation, competitiveness and leadership in the field of TESA / ATMP and ultimately enable clinical translation and commercialisation of the developed technologies.